SONOMA PHARMACEUTICALS, INC. Net Fee Amt
SONOMA PHARMACEUTICALS, INC. (SNOA) had Net Fee Amt of $36.17 as of 2026-07-08, per its S-8 filed 2026-07-09.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-09
- 2026-07-08: Net Fee Amt $36.17.
- 2026-04-17: Net Fee Amt $1.63K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-08 | $36.17 S-8 · filed 2026-07-09 |
| 2026-04-17 | $1.63K S-1 · filed 2026-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |